Delivery Order SPE2DB24D2205-SPE2DB25FEBHK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,904.97 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count packages). This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat overactive bladder, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $5,024.66. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract requires completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) valued at $13,844.76. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The order is scheduled for completion by September 19, 2025, and will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,528.86 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (90 count) on September 10, 2025, with a ceiling value of $7,323.42 and firm fixed pricing. This non-set-aside, competitively awarded contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $28,074.21 on September 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count supply). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $10,190.42. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award to support federal medical procurement needs. The order is set for ultimate completion by July 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $16,088.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.38 to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a medication commonly used to treat overactive bladder. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for pharmaceutical supply of Myrbetriq ER 50 mg tablets (30-count units) with a ceiling value of $2,383.25. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEBHKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $38,427.53. This firm fixed-price, non-set-aside contract is classified as a delivery order and represents a single transaction under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 23, 2025. Myrbetriq is a prescription medication used to treat overactive bladder conditions, reflecting the pharmaceutical supply requirements typical of federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated consistent capability to meet federal requirements through competitive award processes, fulfilling diverse medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.4k | 4/22/25 |